Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally.
$126.56-0.15%
报价 2026-11-06
市值
$4.3B
EV
$5.62B
PE (TTM)
34.2x
预期 PE (FY2026)
20.8x
52 周区间距高点 -0.1%
$67.10$126.75
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 5.90 → 6.86（1.2x） | 18.4 |
| FY+32028-12 | 1.1x | 5.90 → 7.31（1.2x） | 17.3 |
毛利率 24% · TTM 收入 $1824M · 基数 EPS 5.90（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ITGRInteger Holdings Corporation | $4.3B | -0.1% | -1.5% | 24.3% | 34.2x | 18.0x | 38.2x | |
| HAEHaemonetics Corporation | $5.46B | -3.4% | +7.0% | 59.8% | 58.9x | 24.8x | 18.9x | |
| CONConcentra Group Holdings Parent, Inc. | $5.38B | +0.2% | +9.0% | 31.7% | 22.9x | 14.2x | 13.0x | |
| LIVNLivaNova PLC | $4.96B | -1.3% | +10.4% | 67.4% | 25.1x | 22.4x | 38.4x | GARP |
| UFPTUFP Technologies, Inc. | $2.35B | +1.2% | +9.1% | 29.3% | 33.3x | 22.8x | 41.6x | |
| ADUSAddus HomeCare Corporation | $2.32B | -2.0% | +7.1% | 32.2% | 20.3x | 12.9x | 14.1x | |
| RXRXRecursion Pharmaceuticals, Inc. | $2.19B | +0.6% | -3.9% | -49.8% | – | – | – | |
| INSPInspire Medical Systems, Inc. | $1.85B | -3.8% | -5.9% | 85.5% | 14.8x | 22.8x | 17.1x | |
| PRCTPROCEPT BioRobotics Corporation | $1.18B | +1.7% | +21.1% | 66.3% | – | – | – | |
| 同行中位数 | – | – | +8.0% | 46% | 24.0x | 22.6x | 18.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-07-03 Q2 2026 | 2026-04-03 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-26 Q3 2025 | 2025-06-27 Q2 2025 | 2025-03-28 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-27 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $464.1M | $439.6M | $470.9M | $466.6M | $472.8M | $436.2M | $449.5M | $431.4M |
| Gross Margin | 24.3% | 24.9% | 22.5% | 23.2% | 22.7% | 24.3% | 26% | 27.2% |
| Operating Margin | 7.4% | 8% | 10.9% | 11.5% | 11.1% | 11.8% | 12.7% | 13.4% |
| Net Income | $23.6M | $16.5M | $48.6M | $39.7M | $37M | $-22.5M | $32.7M | $35.4M |
| Diluted EPS | 0.69 | 0.48 | 1.38 | 1.11 | 1.04 | -0.66 | 0.9 | 0.99 |
| Operating Cash Flow | $59.7M | $24.7M | $55.4M | $65.6M | $43.9M | $31.3M | $63.2M | $71.5M |